Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Insight Folios Inc

Insight Folios Inc boosted its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 12.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,840 shares of the pharmacy operator’s stock after buying an additional 1,200 shares during the period. Insight Folios Inc’s holdings in Walgreens Boots Alliance were worth $235,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in WBA. AQR Capital Management LLC lifted its stake in shares of Walgreens Boots Alliance by 2.0% in the 3rd quarter. AQR Capital Management LLC now owns 939,006 shares of the pharmacy operator’s stock valued at $20,480,000 after purchasing an additional 18,517 shares during the last quarter. Lido Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 13.7% in the 3rd quarter. Lido Advisors LLC now owns 15,761 shares of the pharmacy operator’s stock valued at $351,000 after purchasing an additional 1,904 shares during the last quarter. Seven Eight Capital LP acquired a new position in shares of Walgreens Boots Alliance in the 3rd quarter valued at $2,331,000. Scotia Capital Inc. lifted its stake in shares of Walgreens Boots Alliance by 1.5% in the 3rd quarter. Scotia Capital Inc. now owns 475,403 shares of the pharmacy operator’s stock valued at $10,573,000 after purchasing an additional 7,227 shares during the last quarter. Finally, Royal London Asset Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 4.3% in the 3rd quarter. Royal London Asset Management Ltd. now owns 307,069 shares of the pharmacy operator’s stock valued at $6,834,000 after purchasing an additional 12,543 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on WBA shares. Bank of America reiterated an “underperform” rating and issued a $11.00 price objective (down previously from $22.00) on shares of Walgreens Boots Alliance in a report on Friday, June 28th. TD Cowen cut their price objective on Walgreens Boots Alliance from $35.00 to $22.00 and set a “buy” rating on the stock in a report on Monday. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a report on Monday. Finally, UBS Group cut their price objective on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a report on Wednesday. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $17.71.

Insider Activity

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari purchased 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The stock was acquired at an average cost of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Stock Down 4.1 %

Shares of NASDAQ WBA opened at $11.10 on Friday. The stock has a market cap of $9.58 billion, a PE ratio of -1.65, a price-to-earnings-growth ratio of 0.77 and a beta of 0.72. The company has a quick ratio of 0.31, a current ratio of 0.65 and a debt-to-equity ratio of 0.49. Walgreens Boots Alliance, Inc. has a 52-week low of $11.10 and a 52-week high of $31.32. The business has a 50-day moving average price of $15.97 and a 200 day moving average price of $19.83.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.68 by ($0.05). Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The company had revenue of $36.40 billion for the quarter, compared to analyst estimates of $35.94 billion. During the same period in the previous year, the business posted $1.00 earnings per share. The firm’s revenue was up 2.8% compared to the same quarter last year. Equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 2.87 earnings per share for the current year.

Walgreens Boots Alliance Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st were issued a $0.25 dividend. The ex-dividend date was Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 9.01%. Walgreens Boots Alliance’s dividend payout ratio is currently -14.84%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.